Table 2.

Additional patient characteristics

PT #	Affected limbs	Onset day	Antibiotics	Initial surgery	Outcome
1	RF, LF	3	Ceftriaxone	FD	Survival
2	RA, LT	2	Ceftriaxone	FD	Survival
3	RH, LH	1	Imipenem & cilastatin sodium, MSD	FD	Survival
4	RH, RH	2	Ceftriaxone	FD	Survival
5	RA, LA	5	Ceftriaxone	FD	Survival
6	RH, LL	1	Ceftriaxone	AMP, FD	Survival
7	RL, LL	1.5	Ceftriaxone	FD	Death
8	RL, LL	1	Imipenem & cilastatin sodium, MSD	FD	Death
9	RL, LL, LH	1	Ceftriaxone	FD	Death
10	RL, LL	1	Ceftriaxone	Bil. AMP	Death
11	RL, LL	1	Ceftriaxone	FD	Death
12	RL, LL	1	Ceftazidime	Bil. AMP	Death
13	RL, LL	1	Ceftriaxone	FD	Death
14	RL, LL	1	Ceftriaxone	FD	Death
15	RL, LF	1	Ceftriaxone	FD	Death
16	RL, LL	1	Ceftazidime	FD	Death
17	RL, LL	1	Ceftriaxone	FD	Death
18	RH, LH	1	Ceftriaxone	Bil. AMP	Death

PT patient, RA right arm, LA left arm, RH right hand, LH left hand, RL right leg, LL left leg, RF right foot, LF left foot, FD fasciotomy and debridement, AMP amputation, Bil. AMP bilateral amputation